{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:07:02Z","timestamp":1789614422985,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shenzhen Science and Technology Program","award":["RCBS20221008093107027"],"award-info":[{"award-number":["RCBS20221008093107027"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303084"],"award-info":[{"award-number":["82303084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"2023 Discipline Leading Talent Project of the Affiliated Hospital of Guizhou Medical University","award":["gyfyxkyc-2023-03"],"award-info":[{"award-number":["gyfyxkyc-2023-03"]}]},{"name":"Hundred-level Talent","award":["Qian Ke He Ping Tai Ren Cai - GCC [2023] 082"],"award-info":[{"award-number":["Qian Ke He Ping Tai Ren Cai - GCC [2023] 082"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03984-8","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:01:54Z","timestamp":1763136114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["INHBA promotes chemoresistance in pancreatic cancer by enhancing CTPS1 stability and mediating pyrimidine metabolism"],"prefix":"10.1186","volume":"25","author":[{"given":"Xinghao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zikai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingkun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dijie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suye","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"3984_CR1","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.2147\/IJN.S413496","volume":"18","author":"H Duan","year":"2023","unstructured":"Duan H, Li L, He S. Advances and prospects in the treatment of pancreatic cancer. Int J Nanomedicine. 2023;18:3973\u201388.","journal-title":"Int J Nanomedicine"},{"key":"3984_CR2","first-page":"2008","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, et al. Pancreat Cancer Lancet. 2020;395:2008\u201320.","journal-title":"Pancreat Cancer Lancet"},{"key":"3984_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102180","volume":"96","author":"S De Dosso","year":"2021","unstructured":"De Dosso S, Siebenh\u00fcner AR, Winder T, et al. Treatment landscape of metastatic pancreatic cancer. Cancer Treat Rev. 2021;96:102180.","journal-title":"Cancer Treat Rev"},{"key":"3984_CR4","first-page":"CD011044","volume":"12","author":"L Haggstrom","year":"2024","unstructured":"Haggstrom L, Chan WY, Nagrial A, et al. Chemotherapy and radiotherapy for advanced pancreatic cancer. Cochrane Database Syst Rev. 2024;12:CD011044.","journal-title":"Cochrane Database Syst Rev"},{"key":"3984_CR5","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.3390\/ijms20184504","volume":"20","author":"S Zeng","year":"2019","unstructured":"Zeng S, P\u00f6ttler M, Lan B, et al. Chemoresistance in pancreatic cancer. Int J Mol Sci. 2019;20:4504.","journal-title":"Int J Mol Sci"},{"key":"3984_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","volume":"19","author":"MA Tempero","year":"2021","unstructured":"Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19:439\u201357.","journal-title":"J Natl Compr Canc Netw"},{"key":"3984_CR7","doi-asserted-by":"publisher","first-page":"C540","DOI":"10.1152\/ajpcell.00331.2022","volume":"324","author":"AK Beutel","year":"2023","unstructured":"Beutel AK, Halbrook CJ. Barriers and opportunities for gemcitabine in pancreatic cancer therapy. Am J Physiol Cell Physiol. 2023;324:C540-540552.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3984_CR8","doi-asserted-by":"crossref","unstructured":"Ganguly K, Bhatia R, Rauth S et al. Mucin 5AC serves as the nexus for \u03b2-Catenin\/c-Myc interplay to promote glutamine dependency during pancreatic cancer chemoresistance. Gastroenterology.\u20092022;162(1):253-268.e13.","DOI":"10.1053\/j.gastro.2021.09.017"},{"key":"3984_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","volume":"32","author":"SK Shukla","year":"2017","unstructured":"Shukla SK, Purohit V, Mehla K, et al. MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer. Cancer Cell. 2017;32:71\u2013e877.","journal-title":"Cancer Cell"},{"key":"3984_CR10","doi-asserted-by":"publisher","first-page":"e2207010","DOI":"10.1002\/advs.202207010","volume":"10","author":"SY Yu","year":"2023","unstructured":"Yu SY, Luan Y, Tang S, et al. Uncovering Tumor-Promoting roles of activin A in pancreatic ductal adenocarcinoma. Adv Sci (Weinh). 2023;10:e2207010.","journal-title":"Adv Sci (Weinh)"},{"key":"3984_CR11","doi-asserted-by":"publisher","first-page":"18065","DOI":"10.1002\/jcp.28439","volume":"234","author":"ZL Chen","year":"2019","unstructured":"Chen ZL, Qin L, Peng XB, et al. INHBA gene silencing inhibits gastric cancer cell migration and invasion by impeding activation of the TGF-\u03b2 signaling pathway. J Cell Physiol. 2019;234:18065\u201374.","journal-title":"J Cell Physiol"},{"key":"3984_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/78161","volume":"25","author":"CW Brown","year":"2000","unstructured":"Brown CW, Houston-Hawkins DE, Woodruff TK, et al. Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions. Nat Genet. 2000;25:453\u20137.","journal-title":"Nat Genet"},{"key":"3984_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41417-020-00237-w","volume":"28","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Wang K, Tan S. Microrna-211-mediated targeting of the INHBA-TGF-\u03b2 axis suppresses prostate tumor formation and growth. Cancer Gene Ther. 2021;28:514\u201328.","journal-title":"Cancer Gene Ther"},{"key":"3984_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413674","author":"X Fan","year":"2025","unstructured":"Fan X, Dai Y, Mo C, et al. TRIM21 promotes tumor growth and gemcitabine resistance in pancreatic cancer by inhibiting EPHX1-mediated arachidonic acid metabolism. Adv Sci. 2025;12(8):e2413674. https:\/\/doi.org\/10.1002\/advs.202413674","journal-title":"Adv Sci"},{"key":"3984_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01381-x","author":"FL Li","year":"2025","unstructured":"Li FL, Gu LH, Tong YL, et al. INHBA promotes tumor growth and induces resistance to PD-L1 blockade by suppressing IFN-\u03b3 signaling. Acta Pharmacol Sin. 2025;46(2):448-461. https:\/\/doi.org\/10.1038\/s41401-024-01381-x","journal-title":"Acta Pharmacol Sin"},{"key":"3984_CR16","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1038\/s41388-021-01906-2","volume":"40","author":"S Hamalian","year":"2021","unstructured":"Hamalian S, G\u00fcth R, Runa F, et al. A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers. Oncogene. 2021;40:5224\u201335.","journal-title":"Oncogene"},{"key":"3984_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1158\/2767-9764.CRC-23-0258","volume":"4","author":"T Abou Kors","year":"2024","unstructured":"Abou Kors T, Hofmann L, Betzler A, et al. INHBA is enriched in HPV-negative oropharyngeal squamous cell carcinoma and promotes cancer progression. Cancer Res Commun. 2024;4:571\u201387.","journal-title":"Cancer Res Commun"},{"key":"3984_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2024.106570","volume":"171","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Chen L, Yang Q, et al. INHBA regulates hippo signaling to confer 5-FU chemoresistance mediated by cellular senescence in colon cancer cells. Int J Biochem Cell Biol. 2024;171:106570.","journal-title":"Int J Biochem Cell Biol"},{"key":"3984_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108300","volume":"240","author":"T Kaur","year":"2022","unstructured":"Kaur T, Weadick B, Mace TA, et al. Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: potential therapeutic opportunities. Pharmacol Ther. 2022;240:108300.","journal-title":"Pharmacol Ther"},{"issue":"63(4):2912-2924","key":"3984_CR20","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1007\/s10528-024-10844-z","volume":"2025 Aug;63(4):","author":"NN Tang","year":"2025","unstructured":"Tang NN, Xu RB, Jiang B, et al. Ahnak2 regulates NF-\u03baB\/MMP-9 signaling to promote pancreatic cancer progression. Biochem Genet. 2025;63(4):2912-2924. https:\/\/doi.org\/10.1007\/s10528-024-10844-z","journal-title":"Biochem Genet"},{"key":"3984_CR21","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1053\/j.gastro.2023.02.025","volume":"164","author":"X Jiang","year":"2023","unstructured":"Jiang X, Ma Y, Wang T, et al. Targeting UBE2T potentiates gemcitabine efficacy in pancreatic cancer by regulating pyrimidine metabolism and replication stress. Gastroenterology. 2023;164:1232\u201347.","journal-title":"Gastroenterology"},{"key":"3984_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00523-y","volume":"8","author":"Y Hu","year":"2024","unstructured":"Hu Y, Recouvreux MS, Haro M, et al. INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer. NPJ Precis Oncol. 2024;8:35.","journal-title":"NPJ Precis Oncol"},{"key":"3984_CR23","doi-asserted-by":"publisher","first-page":"153303382412347","DOI":"10.1177\/15330338241234798","volume":"23","author":"Z Wu","year":"2024","unstructured":"Wu Z, Chen J, Yang L, et al. Elevated INHBA promotes tumor progression of cervical cancer. Technol Cancer Res Treat. 2024;23:15330338241234798.","journal-title":"Technol Cancer Res Treat"},{"key":"3984_CR24","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1186\/s13018-023-04330-2","volume":"18","author":"H Zhang","year":"2023","unstructured":"Zhang H, Huang Y, Wen Q, et al. Inhba gene silencing inhibits proliferation, migration, and invasion of osteosarcoma cells by repressing TGF-\u03b2 signaling pathway activation. J Orthop Surg Res. 2023;18:848.","journal-title":"J Orthop Surg Res"},{"key":"3984_CR25","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/jcmm.17191","volume":"26","author":"ZW Liang","year":"2022","unstructured":"Liang ZW, Yu J, Gu DM, et al. M2-phenotype tumour-associated macrophages upregulate the expression of prognostic predictors MMP14 and INHBA in pancreatic cancer. J Cell Mol Med. 2022;26:1540\u201355.","journal-title":"J Cell Mol Med"},{"key":"3984_CR26","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","volume":"14","author":"J Dilly","year":"2024","unstructured":"Dilly J, Hoffman MT, Abbassi L, et al. Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer. Cancer Discov. 2024;14:2135\u201361.","journal-title":"Cancer Discov"},{"key":"3984_CR27","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202302066","volume":"6","author":"N Minet","year":"2023","unstructured":"Minet N, Boschat AC, Lane R, et al. Differential roles of CTP synthetases CTPS1 and CTPS2 in cell proliferation. Life Sci Alliance. 2023;6:e202302066.","journal-title":"Life Sci Alliance"},{"key":"3984_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12967-021-03206-5","volume":"20","author":"Y Lin","year":"2022","unstructured":"Lin Y, Zhang J, Li Y, et al. CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1. J Transl Med. 2022;20:17.","journal-title":"J Transl Med"},{"key":"3984_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nature13386","volume":"510","author":"E Martin","year":"2014","unstructured":"Martin E, Palmic N, Sanquer S, et al. Ctp synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation. Nature. 2014;510:288\u201392.","journal-title":"Nature"},{"issue":"Suppl 5","key":"3984_CR30","doi-asserted-by":"publisher","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","volume":"17","author":"E Mini","year":"2006","unstructured":"Mini E, Nobili S, Caciagli B, et al. Cellular Pharmacology of gemcitabine. Ann Oncol. 2006;17(Suppl 5):v7\u201312.","journal-title":"Ann Oncol"},{"key":"3984_CR31","doi-asserted-by":"publisher","first-page":"e110620","DOI":"10.15252\/embj.2022110620","volume":"42","author":"K Shigeta","year":"2023","unstructured":"Shigeta K, Hasegawa M, Hishiki T, et al. IDH2 stabilizes HIF-1\u03b1-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. EMBO J. 2023;42:e110620.","journal-title":"EMBO J"},{"key":"3984_CR32","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1242\/jcs.183954","volume":"129","author":"M Akutsu","year":"2016","unstructured":"Akutsu M, Dikic I, Bremm A. Ubiquitin chain diversity at a glance. J Cell Sci. 2016;129:875\u201380.","journal-title":"J Cell Sci"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03984-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03984-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03984-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T01:04:22Z","timestamp":1763168662000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03984-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3984"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03984-8","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Guizhou Medical University Hospital and conducted under its supervision.\u00a0All patients involved in this study have signed written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors agreed to publish the study in the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"403"}}